Tetracycline
We have identified six binding sites for tetracycline in the 30S subunit (
Table II;
Figure 1A) but found no common structural trait among the binding sites. The questions arise, which sites could affect translation and to what extent are they involved in the inhibitory action of tetracycline? Tet‐1, the site with the highest relative occupancy (
Table II;
Figure 2A), interferes with the location where the A‐site tRNA (
Cate et al., 1999) was docked onto the 30S structure (
Schlünzen et al., 2000). Thus, tetracycline can physically prevent the binding of the tRNA to the A‐site. This mode of interaction is consistent with the classical model of tetracycline as an inhibitor of A‐site occupation, and hence offers a clear explanation for the bacteriostatic effect of tetracycline.
There are two ribosome‐related mechanisms of tetracycline resistance in bacteria. Both are linked to the Tet‐1 site. In one, resistance is mediated by ribosomal protection proteins (
Roberts, 1996) and in the other by the mutation 1058G→C on 16S rRNA (
Ross et al., 1998). Ribosomal protection proteins, such as TetM, TetO and TetS, confer resistance only at low concentrations of tetracycline, and show some sequence and structural homology with the elongation factors G and EF‐Tu (
Dantley et al., 1998). It has been proposed that TetM binds to the A‐site and upon GTP hydrolysis actively releases the tetracycline bound to it (
Dantley et al., 1998). The G1058→C mutation could hamper the base pairing of G1058 with U1199 and might lead to a conformational change that results in closing the Tet‐1‐binding pocket. This conformational change may be due to the release of the coordinating Mg
2+ ion.
These two tetracycline resistance mechanisms reflect the importance of the Tet‐1‐binding site in the antibiotic action of tetracycline. However, the presence of five additional binding sites, the biochemical evidence for different locations of tetracycline and the low level of resistance conferred by the ribosomal protection proteins demand more complex explanations about the possible functional relevance of the five additional sites. Binding of tetracycline to Tet‐4, ‐5 and ‐6 sites is supported by biochemical evidence (
Table II), but there are no biochemical data on Tet‐2 and ‐3 sites. The Tet‐5 site is located between H11 and H27, the switch helix (
Lodmell and Dahlberg, 1997), which is a functional hot spot (
Figure 2E). Tetracycline bound to the Tet‐5 position could limit the mobility needed by H27 to switch between the 912–885, or error prone conformation, and the 912–888, or restrictive conformation (
Lodmell and Dahlberg, 1997). Therefore, tetracycline bound at Tet‐5 could lock the 30S subunit into one of these two conformations.
Only four proteins, namely S4 for Tet‐2, S7 for Tet‐6, S9 for Tet‐4 and ‐6, and S17 for Tet‐5, come into contact with tetracycline. S4, S7, S9 and S17 are primary rRNA‐binding proteins (
Held et al., 1974). S4 and S7 are the two proteins that initiate the assembly of the 30S subunit (
Nowotny and Nierhaus, 1988). Therefore, tetracycline binding at the Tet‐2, ‐4, ‐5 and ‐6 sites may not influence the decoding process, but could disturb the early assembly steps of new 30S particles, contributing to the overall inhibitory effect of tetracycline.
Overall, our data for the six positions can explain well the sometimes contradictory reported biochemical and functional data for tetracycline binding to the 30S subunits (
Table II). We show that physical blockage of the A‐site tRNA binding by tetracycline bound at Tet‐1 can account for the inhibitory action of tetracycline, but we can not say with certainty that any of the five minor sites is involved in tetracycline action. Nevertheless, we hypothesize that, with the exception of tetracycline at the Tet‐3 site, these sites could act synergistically to contribute to the bacteriostatic effect of tetracycline.
Edeine
We found one 30S‐binding site for edeine (
Figures 1A and
2F), in contrast to the six sites of tetracycline. All the rRNA bases defining the edeine‐binding site are conserved in chloroplasts, mitochondria and the three phylogenetic domains, explaining why edeine is said to be a universal protein synthesis inhibitor (
Altamura et al., 1988). Interestingly, the 16S rRNA bases involved in edeine binding are also conserved in
B.brevis, the organism that synthesizes it. Thus, edeine acts equally well as a protein synthesis inhibitor on
B.brevis ribosomes (
Kurylo‐Borowska, 1975), which resolves this apparent paradox by rapidly releasing the active edeine into the growth medium, and by only maintaining low concentrations of inactive edeine attached to the internal part of the cell membrane (
Kurylo‐Borowska, 1975).
The binding of edeine involves nucleotides situated in H24, H28, the neck helix, H44, the core of the decoding region and in its close neighbor H45, which is also involved in the decoding process (
Figure 2F). Mutations in G791 and A792 (H24) reduce association of the 30S and 50S subunits, and an A792 mutant is associated with loss of IF3 binding (
Tapprich et al., 1989;
Santer et al., 1990). G926 (H28) interacts with the tRNA bound at the P‐site and is protected by edeine (
Woodcock et al., 1991). Furthermore, mutations in U1498 impair A‐site function and enhance tRNAfMet selectivity (
Ringquist et al., 1993), while mutations in G1505 increase the levels of stop codon read‐through and frameshifting (
O'Connor et al., 1995,
1997). By physically linking these four helices, critical points for tRNA, IF3 and mRNA binding, edeine could lock the small subunit in a fixed configuration and hinder the conformational changes that are thought to accompany the translation process (
Gabashvili et al., 1999b;
VanLoock et al., 2000).
In addition to the direct interactions of edeine with the 16S bases (
Table II), our structure shows that edeine induces the formation of a base pair between C795 at the loop of H24 and G693 at the loop of H23 (
Figure 2F). Although neither G693 nor C795 is directly involved in edeine binding, G693 has been shown to be protected when edeine is bound (
Woodcock et al., 1991). Thus, the formation of this base pair explains the protection against chemical attack of G693 upon edeine binding.
H23 plays an important role in the binding of the C‐terminal domain of IF3 (
Table II), and nucleotides 787–795 of H24 are directly involved in 30S–50S subunit association (
Tapprich and Hill, 1986). Analysis of our structure shows that the G693–C795 base pair would impose constraints on the mobility of the platform, which is believed to move during translation (
Gabashvili et al., 1999a). Based on these findings, it is conceivable that the formation of the G693–C795 base pair interferes substantially with both elongation and initiation. Existing biochemical data on edeine binding to the 30S subunit support this hypothesis. These data suggest that edeine blocks not only initiation (
Odon et al., 1978), but also elongation, by interfering with the P‐site tRNA (
Moazed and Noller, 1987). It is possible that in prokaryotes and Archaea, the G693–C795 base pair blocks the path of the mRNA between the decoding region and the anti‐SD region of the 16S rRNA.
This blockage would make the anti‐SD region on the 16S rRNA less accessible and thus it would not base pair with the incoming mRNA during the initial stages of initiation. This effect on the mRNA path seems to be universal since edeine interacts with G926 and G693, two universally conserved nucleotides. G926 (H28) has been photo‐cross‐linked in
E.coli to position +2 of the mRNA (
Sergiev et al., 1997) and to position +1 in human ribosomes (
Demeshkina et al., 2000). G693, on the other hand, has been photo‐cross‐linked in
E.coli to positions −1/−3 of the mRNA (
Bhangu and Wollenzien, 1992) and in human ribosomes to position −3 of the mRNA (
Demeshkina et al., 2000).
The only mutant resistant to edeine that has been functionally characterized is a mutant of
Saccharomyces cerevisiae. This mutant overcomes edeine inhibition by an increased affinity for mRNA (
Herrera et al., 1984). In eukaryotes, where the initial docking of the mRNA is independent of base complementarity between the mRNA and the 18S rRNA, an increased affinity of the small subunit for mRNA could indeed promote edeine resistance. The cross‐link of G693 with positions −1/−3 of the mRNA, together with the formation of the cross‐helix base pair (G693–C795) induced by edeine in our structure, offer a good explanation as to why edeine interferes with the AUG recognition process in eukaryotes. It was shown that in the presence of edeine the 40S ribosome complex (tRNA–eIF2–GTP and other factors) scans along the mRNA without recognizing the AUG start codon (
Kozak and Shatkin, 1978). The structure of the 30S–edeine complex shows that the path of the mRNA is altered, mainly in the region of the small subunit that should interact with the mRNA initiation codon, and thus should hamper the formation of the 80S initiation complex. Based on these findings, we conclude that the effect of edeine is to alter the path of the mRNA through the small ribosomal subunit, thereby affecting initiation as well as tRNA binding to the P‐site and possibly even to the E‐site.
In summary, our structural results are not only consistent with the biochemical data on edeine binding, but can also explain the involvement of edeine in the inhibition of the initiation and elongation processes. Our data suggest that the initiation process is the main target of this universal antibiotic. The fact that edeine induces an allosteric change of this nature—forming a new base pair—could be an important principle of antibiotic action never reported previously.
IF3
IF3C binds to the 30S particle at the upper end of the platform on the solvent side of 30S (
Figure 3A), close to the anti‐SD region of the 16S rRNA. IF3C does not bind at the inter‐subunit interface of the 30S and 50S subunits, and therefore its anti‐association activity is not the product of physical blockage at the interface between the two subunits.
EM reconstructions of rat liver 40S in complex with the eukaryotic initiation factor 3 (eIF3) located eIF3 in a comparable region at the upper edge of the platform (
Srivastava et al., 1992). The agreement with our results indicates that certain mechanisms underlying the initiation process have been evolutionarily conserved. This hypothesis is also supported by the results obtained for the 30S–edeine complex. In contrast, a more recent cryo‐EM study on the
Thermus small ribosomal subunit (
McCutcheon et al., 1999) localized IF3C on the side of the platform facing the subunit interface, suggesting a different mechanism for IF3C action.
Based on the location of IF3C that we observed, it is likely that the binding of IF3C to the 30S subunit influences the mobility of H45. The binding at this site could affect the conformational dynamics and thus prevent the association of the two ribosomal subunits. Our suggestion is supported by the observation that the double mutant of G1530/A1531 to A1530/G1531 in H45 of the 16S rRNA reduces IF3 binding to the 30S subunit 10‐fold (
Firpo et al., 1996). Moreover, this double mutant enhances IF3 affinity for the 70S ribosomes, and IF3 is unable to promote the dissociation of 70S ribosomes carrying this mutation (
Firpo et al., 1996). Our structural results are consistent with these biochemical observations and support the hypothesis that IF3C binding alone is not sufficient to prevent subunit association or promote dissociation, but rather it acts by changing the conformational dynamics of the subunit. These results also support our finding that IF3C does not physically block the inter‐subunit interface between the 30S and 50S subunit.
The spatial proximity of the IF3C‐binding site to the anti‐SD region of the 16S rRNA suggests a connection between IF3C binding and mRNAs interacting with the anti‐SD region. The interaction of mRNA with the anti‐SD region and with IF3 could suppress the change in the conformational dynamics induced by IF3, thus allowing subunit association. This could also explain the observation that leaderless mRNAs are only translated at low intracellular concentrations of IF3 (
Tedin et al., 1999). In the absence of the leader sequence (SD), the change in conformational dynamics induced by IF3 would not be reversed, and thus subunits will not be able to form the 70S initiation complex.
It has been suggested that the flexibility and the ability of the linker region to alter its fold are partially related to the function of IF3 in the formation of the initiation complex, and thus it has a functional importance. Assuming that our IF3N placement is correct, the linker region between IF3C and IF3N needs to be flexible. Indeed, the extreme flexibility of the linker region of IF3 was shown biochemically (
de Cock et al., 1999) as well as by NMR studies (
Moreau et al., 1997). Our results also agree with the proposal that the linker maintains its flexibility when IF3 is bound to the 30S subunit. Thus, it is possible that once the IF3N and IF3C domains are bound, the linker acts as a strap between the two domains. In this manner, the IF3 linker could indirectly affect the conformation of the P‐site and induce its specificity for tRNAfMet (
de Cock et al., 1999). The location of the docked IF3N (
Figure 3A) suggests that codon–anticodon recognition may be based on space‐exclusion principles, rather than specific interactions of IF3 with the codon– anticodon complementarity mechanism, as suggested (
Meinnel et al., 1999).
In summary, our localization of IF3C on the 30S subunit and the modeling of the linker region and of the IF3N‐binding site provide a connection between IF3 function and the existing biochemical data. Our IF3C location (
Figure 3C) shows clearly that the anti‐association activity of IF3 is not due to physical blockage of the inter‐subunit interface, but rather to a change in the conformational dynamics of the subunit. It also explains the correlation between the binding of IF3 to the small ribosomal subunit and the mRNA requirement to interact with the anti‐SD region of 16S rRNA for efficient translation.
A related crystallographic study (
Brodersen et al., 2000) was published during the reviewing period of this manuscript. It reports the binding of three antibiotics: tetracycline, for which two sites were revealed; pactamycin, which shares a similar chemical protection pattern to edeine; and hygromycin. Initial inspection shows considerable similarities between the reported tetracycline‐binding sites and Tet‐1 and ‐5 resolved by us. It also shows that pactamycin binding bridges H23 and H24 while edeine induces a base pair having the same bridging effect. The agreement between these independently obtained results confirms the reliability of both studies and shows clearly that the high resolution structure of the small ribosomal subunit offers excellent possibilities for illuminating the molecular bases for the modes of action of antibiotics and various other factors that affect ribosomal function.